Page 747 - Williams Hematology ( PDFDrive )

722 Part VI: The Erythrocyte Chapter 47: Erythrocyte Enzyme Disorders 723

591. Jacob H, Jandl JH: A simple visual screening test for G6PD deficiency employing ascor- 623. Al Rimawi HS, Al Sheyyab M, Batieha A, et al: Effect of desferrioxamine in acute hae-
bate and cyanide. N Engl J Med 274:1162–1167, 1966. molytic anaemia of glucose-6-phosphate dehydrogenase deficiency. Acta Haematol.
592. Oski FA: Red cell metabolism in the newborn infant. V. Glycolytic intermediates and 101:145–148, 1999.
glycolytic enzymes. Pediatrics 44:84–91, 1969. 624. Ekert H, Rawlinson I: Deferoxamine and favism. N Engl J Med 312:1260, 1985.
593. Travis SF, Kumar SP, Paez PC, et al: Red cell metabolic alterations in postnatal life in 625. Makarona K, Caputo VS, Costa JR, et al: Transcriptional and epigenetic basis for
term infants: Glycolytic enzymes and glucose-6-phosphate dehydrogenase. Pediatr Res restoration of G6PD enzymatic activity in human G6PD-deficient cells. Blood 124:
14:1349–1352, 1980. 134–141, 2014.
594. Gross RT, Schroeder EA, Brounstein SA: Energy metabolism in the erythrocytes of pre- 626. Ationu A, Humphries A, Lalloz MR, et al: Reversal of metabolic block in glycoly-
mature infants compared to full term newborn infants and adults. Blood 21:755–763, sis by enzyme replacement in triosephosphate isomerase-deficient cells. Blood 94:3
1963. 193–3198, 1999.
595. Lestas AN, Rodeck CH, White JM: Normal activities of glycolytic enzymes in the fetal 627. Tanphaichitr VS, Suvatte V, Issaragrisil S, et al: Successful bone marrow transplanta-
erythrocytes. Br J Haematol 50:439–444, 1982. tion in a child with red blood cell pyruvate kinase deficiency. Bone Marrow Transplant
596. Konrad PN, Valentine WN, Paglia DE: Enzymatic activities and glutathione content of 26:689–690, 2000.
erythrocytes in the newborn: Comparison with red cells of older normal subjects and 628. Kanno H, Aisaki, K.-I., Hamada T, et al: Ex vivo treatment of erythroid cells with gly-
those with comparable reticulocytosis. Acta Haematol 48:193–201, 1972. colytic intermediates for metabolic correction of pyruvate kinase deficiency [abstract].
597. Carrell RW, Kay R: A simple method for the detection of unstable haemoglobins. Br J Blood 104: P3689, 2004.
Haematol. 23:615–619, 1972. 629. Kung C, Hixon J, Kosinski P, et al: Small molecule activation of pyruvate kinase normal-
598. Valentine WN, Paglia DE, Fink K, et al: Lead poisoning. Association with hemolytic izes metabolic activity in red cells from patients with pyruvate kinase deficiency-associ-
anemia, basophilic stippling, erythrocyte pyrimidine 5′-nucleotidase deficiency, and ated hemolytic anemia, in American Society of Hematology (ASH) 55th Annual meeting,
intraerythrocytic accumulation of pyrimidines. J Clin Invest 58:926–932, 1976. New Orleans, LA, 2013.
599. Beutler E, Kuhl W, Fox M, et al: Prenatal diagnosis of glucose-6-P dehydrogenase 630. Schroter W: Successful long-term phenobarbital therapy of hyperbilirubinemia in con-
(G6PD) deficiency. Acta Haematol 87:103–104, 1992. genital hemolytic anemia due to glucose phosphate isomerase deficiency. Eur J Pediatr
600. Baronciani L, Beutler E: Prenatal diagnosis of pyruvate kinase deficiency. Blood 135:41–43, 1980.
84:2354–2356, 1994. 631. Andersen FD, d’Amore F, Nielsen FC, et al: Unexpectedly high but still asymptomatic
601. Rouger H, Girodon E, Goossens M, et al: PK Mondor: Prenatal diagnosis of a frame- iron overload in a patient with pyruvate kinase deficiency. Hematol J 5:543–545, 2004.
shift mutation in the LR pyruvate kinase gene associated with severe hereditary non 632. Rider NL, Strauss KA, Brown K, et al: Erythrocyte pyruvate kinase deficiency in an
-spherocytic haemolytic anaemia. Prenat Diagn 16:97–104, 1996. old-order Amish cohort: Longitudinal risk and disease management. Am J Hematol
602. Gupta N, Bianchi P, Fermo E, et al: Prenatal diagnosis for a novel homozygous mutation 86:827–834, 2011.
in PKLR gene in an Indian family. Prenat Diagn 27:117–118, 2007. 633. Zanella A, Berzuini A, Colombo MB, et al: Iron status in red cell pyruvate kinase defi-
603. Kedar PS, Nampoothiri S, Sreedhar S, et al: First-trimester prenatal diagnosis of pyru- ciency: Study of Italian cases. Br J Haematol 83:485–490, 1993.
vate kinase deficiency in an Indian family with the pyruvate kinase-Amish mutation. 634. Finkenstedt A, Bianchi P, Theurl I, et al: Regulation of iron metabolism through GDF15
Genet Mol Res 6:470–475, 2007. and hepcidin in pyruvate kinase deficiency. Br J Haematol 144:789–793, 2009.
604. So C-C, Tang M, Li C-H, et al: First reported case of prenatal diagnosis for pyruvate 635. Mojzikova R, Koralkova P, Holub D, et al: Iron status in patients with pyruvate kinase
kinase deficiency in a Chinese family. Hematology 16:377–379, 2011. deficiency: Neonatal hyperferritinaemia associated with a novel frameshift deletion in
605. Pekrun A, Neubauer BA, Eber SW, et al: Triosephosphate isomerase deficiency: Bio- the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios. Br J Haematol 165:
chemical and molecular genetic analysis for prenatal diagnosis. Clin Genet 47:175–179, 556–563, 2014.
1995. 636. Pannacciulli I, Tizianello A, Ajmar F, et al: The course of experimentally-induced
606. Repiso A, Corrons JL, Vulliamy T, et al: New haplotype for the Glu104Asp mutation hemolytic anemia in a primaquine- sensitive Caucasian. A case study. Blood 25:92–95,
in triose-phosphate isomerase deficiency and prenatal diagnosis in a Spanish family. J 1965.
Inherit Metab Dis 28:807–809, 2005. 637. Meloni T, Forteleoni G, Noja G, et al: Increased prevalence of glucose-6-phosphate
607. Arya R, Lalloz MR, Nicolaides KH, et al: Prenatal diagnosis of triosephosphate dehydrogenase deficiency in patients with cholelithiasis. Acta Haematol 85:76–78,
isomerase deficiency. Blood 87:4507–4509, 1996. 1991.
608. Hirono A, Forman L, Beutler E: Enzymatic diagnosis in non-spherocytic hemolytic 638. Petrakis NL, Wiesenfeld SL, Sams BJ, et al: Prevalence of sickle-cell trait and glucose-6-
anemia. Medicine (Baltimore) 67:110–117, 1988. phosphate dehydrogenase deficiency. N Engl J Med 282:767–770, 1970.
609. Beutler E, Luzzatto L: Hemolytic anemia. Semin Hematol 36:38–47, 1999. 639. Heller P, Best WR, Nelson RB, et al: Clinical implications of sickle-cell trait and
610. von Löhneysen K, Scott TM, Soldau K, et al: Assessment of the red cell proteome of glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N
young patients with unexplained hemolytic anemia by two-dimensional differential Engl J Med 300:1001–1005, 1979.
in-gel electrophoresis (DIGE). PLoS One 7:e34237, 2012. 640. Renzaho AM, Husser E, Polonsky M: Should blood donors be routinely screened for
611. Barasa B, Slijper M: Challenges for red blood cell biomarker discovery through pro- glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies
teomics. Biochim Biophys Acta 1844:1003–1010, 2014. focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red
612. Bordbar A, Jamshidi N, Palsson BO: iAB-RBC-283: A proteomically derived cells. Transfus Med Rev 28:7–17, 2014.
knowledge-base of erythrocyte metabolism that can be used to simulate its physiologi- 641. Pilo F, Baronciani D, Depau C, et al: Safety of hematopoietic stem cell donation in glu-
cal and patho-physiological states. BMC Syst Biol 5:110, 2011. cose 6 phosphate dehydrogenase-deficient donors. Bone Marrow Transplant 48:36–39,
613. Lyon GJ, Jiang T, Van Wijk R, et al: Exome sequencing and unrelated findings in the 2013.
context of complex disease research: Ethical and clinical implications. Discov Med 642. Pamba A, Richardson ND, Carter N, et al: Clinical spectrum and severity of hemolytic
12:41–55, 2011. anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone [in
614. Mimouni F, Shohat S, Reisner SH: G6PD-deficiency donor blood as a cause of hemoly- process citation]. Blood 120:4123–4133, 2012.
sis in two preterm infants. Isr J Med Sci 22:120–122, 1986. 643. Bowman HS, McKusick VA, Dronamraju KR: Pyruvate kinase deficient hemolytic ane-
615. Kappas A, Drummond GS, Valaes T: A single dose of Sn-mesoporphyrin prevents mia in an Amish isolate. Hum GenetAm J Hum Genet 17:1–8, 1965.
development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase- 644. Beutler E, Duron O, Kelly BM: Improved method for the determination of blood gluta-
deficient newborns. Pediatrics 108:25–30, 2001. thione. J Lab Clin Med 61:882–890, 1963.
616. Hamilton JW, Jones FG, McMullin MF: Glucose-6-phosphate dehydrogenase Guada- 645. Beutler E, Gelbart T: Improved assay of the enzymes of glutathione synthesis: Gam-
lajara—a case of chronic non-spherocytic haemolytic anaemia responding to splenec- ma-glutamylcysteine synthetase and glutathione synthetase. Clin Chim Acta 158:
tomy and the role of splenectomy in this disorder. Hematology 9:307–309, 2004. 115–123, 1986.
617. Baronciani L, Tricta F, Beutler E: G6PD “campinas:” A deficient enzyme with a muta- 646. Valentine WN, Fink K, Paglia DE, et al: Hereditary hemolytic anemia with human ery-
tion at the far 3′ end of the gene. Hum Mutat 2:77–78, 1993. throcyte pyrimidine 5′-nucleotidase deficiency. J Clin Invest 54:866–879, 1974.
618. Beutler E, Mathai CK, Smith JE: Biochemical variants of glucose-6-phosphate dehydro- 647. Torrance J, West C, Beutler E: A simple rapid radiometric assay for pyrimidine-5′-
genase giving rise to congenital nonspherocytic hemolytic disease. Blood 31:131–150, nucleotidase. J Lab Clin Med 90:563–568, 1977.
1968. 648. Beutler E, Kuhl W, Gelbart T: Blood cell phosphogluconolactonase: Assay and proper-
619. Corash L, Spielberg S, Bartsocas C, et al: Reduced chronic hemolysis during high-dose ties. Br J Haematol. 62:577–586, 1986.
vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase 649. Bird TD, Hamernyik P, Nutter JY, et al: Inherited deficiency of delta-aminolevulinic
deficiency. N Engl J Med 303:416–420, 1980. acid dehydratase. Am J Hum Genet 31:662–668, 1979.
620. Spielberg SP, Boxer LA, Corash LM, et al: Improved erythrocyte survival with high dose 650. Kamatani N, Hakoda M, Otsuka S, et al: Only three mutations account for almost all
vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies. Ann defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese
Intern Med 90:53–54, 1978. patients. J Clin Invest 90:130–135, 1992.
621. Johnson GJ, Vatassery GT, Finkel B, et al: High-dose vitamin E does not decrease the 651. Hidaka Y, Palella TD, O’Toole TE, et al: Human adenine phosphoribosyltransferase.
rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. N Engl J Identification of allelic mutations at the nucleotide level as a cause of complete defi-
Med 308:1014–1017, 1983. ciency of the enzyme. J Clin Invest 80:1409–1415, 1987.
622. Newman JG, Newman TB, Bowie LJ, et al: An examination of the role of vitamin E in 652. Resta R, Thompson LF: SCID: The role of adenosine deaminase deficiency. Immunol
glucose-6-phosphate dehydrogenase deficiency. Clin Biochem 12:149–151, 1979. Today 18:371–374, 1997.

Kaushansky_chapter 47_p0689-0724.indd 722 9/17/15 6:45 PM